Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Leri

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Experimental and Clinical Psychopharmacology|December 22, 2005
Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individualsFrancesco Leri, Jane Stewart, Benedikt Fischer, et al.
Drug and Alcohol Dependence|October 20, 2006
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid usersNeerav Monga, Jürgen Rehm, Benedikt Fischer, et al.
Psychopharmacology|June 20, 2020
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male ratsSamantha M Ayoub, Reem Smoum, Mathew Farag, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Affective Disorders|January 24, 2020
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkersStephen Daniels, Thomas Horman, Thomas Lapointe, et al.
Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry|September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 studyFarhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry|May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant TreatmentRaoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Experimental and Clinical Psychopharmacology|December 22, 2005
Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individualsFrancesco Leri, Jane Stewart, Benedikt Fischer, et al.
Drug and Alcohol Dependence|October 20, 2006
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid usersNeerav Monga, Jürgen Rehm, Benedikt Fischer, et al.
Psychopharmacology|June 20, 2020
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male ratsSamantha M Ayoub, Reem Smoum, Mathew Farag, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Affective Disorders|January 24, 2020
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkersStephen Daniels, Thomas Horman, Thomas Lapointe, et al.
Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry|September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 studyFarhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry|May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant TreatmentRaoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Pageof 11